Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1

Arthritis Research and Therapy

Volumn 6, Issue 4, 2004, Pages

  Allanore, Yannick ^a   Borderie, Didier ^a   Lemaréchal, Hervé ^a   Ekindjian, Ohvanesse Garabed ^a   Kahan, André ^a  

^a Cochin Hospital ^*  (France)

Author keywords

nifedipine; oxidative stress; sVCAM 1; systemic sclerosis; VEGF

Indexed keywords

BIOLOGICAL MARKER; NIFEDIPINE; PLASMA PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ARTICLE; BLOOD; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROSPECTIVE STUDY; SOLUBILITY; SYSTEMIC SCLEROSIS;

BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NIFEDIPINE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SCLERODERMA, SYSTEMIC; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16644379903     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1183     Document Type: Article

References (28)

1. LeRoy EC: Systemic sclerosis: a vascular perspective. Rheum Dis Clin North Am. 1996, 22: 675-694. DOI: 10.1016/S0889-857X(05)70295-7
2. Fleiszchmajer R, Perlish JS: Capillary alterations in scleroderma. J Am Acad Dermatol. 1980, 2: 161-170. DOI: 10.1016/S0190-9622(80)80396-3
3. Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G: Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum. 2000, 43: 2550-2562. 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H. DOI: 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H
4. Cerinic MM, Valentini G, Sorano GG, D'Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Pignone A, Guiducci S, Del Rosso A, Kalfin R, Das D, Marongiu F: Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum. 2003, 32: 285-295. 10.1053/sarh.2002.50011. DOI: 10.1053/sarh.2002.50011
5. Altman RD, Medsger TA, Bloch DA, Michel BA: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum. 1991, 34: 403-413. DOI: 10.1002/art.1780340405
6. Kahaleh B, Meyer O, Scorza R: Assessment of vascular involvement. Clin Exp Rheumatol. 2003, Suppl 29: S9-S14.
7. Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO, Dubois RM, Black CM: Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol. 1995, 34: 1048-1054. DOI: 10.1093/rheumatology/34.11.1048
8. Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K: Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol. 1998, 139: 1049-1051. 10.1046/j.1365-2133.1998.02563.x. DOI: 10.1046/j.1365-2133.1998.02563.x
9. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Bruhlmann P, Muller-Ladner U, Gay S, Matucci-Cerinic M: Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002, 4: R11-10.1186/ar596. DOI: 10.1186/ar596
10. Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS, Park KS, Seo YI, Kim WU, Park SH, Cho CS: Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol. 2003, 30: 1529-1533.
11. Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B: Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum. 2000, 43: 889-893. 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5. DOI: 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5
12. Shibuya M: Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol. 2001, 33: 409-420. 10.1016/S1357-2725(01)00026-7. DOI: 10.1016/S1357-2725(01)00026-7
13. Maulik N, Das DK: Redox signaling in vascular angiogenesis. Free Radic Biol Med. 2002, 33: 1047-1060. 10.1016/S0891-5849(02)01005-5. DOI: 10.1016/S0891-5849(02)01005-5
14. Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM, Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC: Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000, 155: 1-15. 10.1016/S0300-483X(00)00272-9. DOI: 10.1016/S0300-483X(00)00272-9
15. Thompson AE, Shea B, Welch V, Fenlon D, Pope JE: Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis Rheum. 2001, 44: 1841-1847. 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8. DOI: 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8
16. Duboc D, Kahan A, Maziere B, Loc'h C, Crouzel C, Menkes CJ, Amor B, Strauch G, Guerin F, Syrota A: The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study. Arthritis Rheum. 1991, 34: 198-203. DOI: 10.1002/art.1780340211
17. Allanore Y, Borderie D, Lemaréchal H, Ekindjian OG, Kahan A: Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am J Med. 2004, 116: 595-600. 10.1016/j.amjmed.2003.11.022. DOI: 10.1016/j.amjmed.2003.11.022
18. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 1: 202-205.
19. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233: 357-363. DOI: 10.1016/S0076-6879(94)33041-7
20. Witko-Sarsat V, Friedlander M, Capelliere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49: 1304-1313. DOI: 10.1038/ki.1996.186
21. Shahin AA, Anwar S, Elawar AH, Sharaf AE, Hamid MA, Eleinin AA, Eltablawy M: Circulating soluble adhesion molecules in patients with systemic sclerosis: correlation between circulating soluble vascular cell adhesion molecule-1 (sVCAM-1) and impaired left ventricular diastolic function. Rheumatol Int. 2000, 20: 21-4. 10.1007/s002960000072. DOI: 10.1007/s002960000072
22. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol. 1992, 166: 255-263. DOI: 10.1002/path.1711660307
23. Fukuo K, Yang J, Yasuda O, Mogi M, Suhara T, Sato N, Suzuki T, Morimoto S, Ogihara T: Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways. Circulation. 2002, 106: 356-361. 10.1161/01.CIR.0000021924.02006.BA. DOI: 10.1161/01.CIR.0000021924.02006.BA
24. Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, Black CM: Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum. 1999, 42: 2646-2655. 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T. DOI: 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T
25. Kahan A, Devaux JY, Amor B, Menkes CJ, Weber S, Nitenberg A, Venot A, Guerin F, Degeorges M, Roucayrol JC: Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med. 1986, 314: 1397-1402. DOI: 10.1056/NEJM198605293142201
26. Rademaker M, Meyrick Thomas RH, Kirby JD, Kovacs IB: The anti-platelet effect of nifedipine in patients with systemic sclerosis. Clin Exp Rheumatol. 1992, 10: 57-62.
27. Sugano M, Tsuchida K, Makino N: Nifedipine prevents apoptosis of endothelial cells induced by oxidized low-density lipoproteins. J Cardiovasc Pharmacol. 2002, 40: 146-152. 10.1097/00005344-200207000-00018. DOI: 10.1097/00005344-200207000-00018
28. Carsten Hornig, Bernhard Barleon, Shakil Ahmad, Piia Vuorela, Asif Ahmed, Herbert A Weich: Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest. 2000, 80: 443-454. DOI: 10.1038/labinvest.3780050